These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9755360

  • 1. Effects of meta-chlorophenylpiperazine on cerebral blood flow in obsessive-compulsive disorder and controls.
    Ho Pian KL, Westenberg HG, den Boer JA, de Bruin WI, van Rijk PP.
    Biol Psychiatry; 1998 Sep 01; 44(5):367-70. PubMed ID: 9755360
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of the serotonergic agonist mCPP on male rats in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
    Tucci MC, Dvorkin-Gheva A, Graham D, Amodeo S, Cheon P, Kirk A, Peel J, Taji L, Szechtman H.
    Psychopharmacology (Berl); 2013 May 01; 227(2):277-85. PubMed ID: 23354534
    [Abstract] [Full Text] [Related]

  • 5. Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions.
    Lucey JV, Costa DC, Blanes T, Busatto GF, Pilowsky LS, Takei N, Marks IM, Ell PJ, Kerwin RW.
    Br J Psychiatry; 1995 Nov 01; 167(5):629-34. PubMed ID: 8564319
    [Abstract] [Full Text] [Related]

  • 6. Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder.
    Pian KL, Westenberg HG, van Megen HJ, den Boer JA.
    Psychopharmacology (Berl); 1998 Dec 01; 140(3):365-70. PubMed ID: 9877016
    [Abstract] [Full Text] [Related]

  • 7. m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation.
    Goodman WK, McDougle CJ, Price LH, Barr LC, Hills OF, Caplik JF, Charney DS, Heninger GR.
    Biol Psychiatry; 1995 Aug 01; 38(3):138-49. PubMed ID: 7578657
    [Abstract] [Full Text] [Related]

  • 8. The comparison of pre- and post-treatment (99m)Tc HMPAO brain SPECT images in patients with obsessive-compulsive disorder.
    Karadağ F, Kalkan Oğuzhanoğlu N, Yüksel D, Kıraç S, Cura C, Ozdel O, Ateşci F.
    Psychiatry Res; 2013 Aug 30; 213(2):169-77. PubMed ID: 23149026
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Caudate regional cerebral blood flow in obsessive-compulsive disorder, panic disorder and healthy controls on single photon emission computerised tomography.
    Lucey JV, Costa DC, Busatto G, Pilowsky LS, Marks IM, Ell PJ, Kerwin RW.
    Psychiatry Res; 1997 Mar 14; 74(1):25-33. PubMed ID: 10710160
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Meta-Chlorophenylpiperazine-Induced Behavioral Changes in Obsessive-Compulsive Disorder Research: A Systematic Review of Rodent Studies.
    da Silva JF, Taguchi LM, Leite EDS, de Oliveira AR.
    Neuroscience; 2022 Dec 15; 507():125-138. PubMed ID: 36332691
    [Abstract] [Full Text] [Related]

  • 13. Pharmacotherapy and regional cerebral blood flow in children with obsessive compulsive disorder.
    Diler RS, Kibar M, Avci A.
    Yonsei Med J; 2004 Feb 29; 45(1):90-9. PubMed ID: 15004874
    [Abstract] [Full Text] [Related]

  • 14. Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan.
    Gross-Isseroff R, Cohen R, Sasson Y, Voet H, Zohar J.
    Neuropsychobiology; 2004 Feb 29; 50(3):200-5. PubMed ID: 15365215
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP.
    Pigott TA, Hill JL, Grady TA, L'Heureux F, Bernstein S, Rubenstein CS, Murphy DL.
    Biol Psychiatry; 1993 Jan 01; 33(1):3-14. PubMed ID: 8420593
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.